Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

What Are the SARA, LEMOCOT & 9-Hole Peg Tests for ARSACS?

At a Glance

The SARA, LEMOCOT, and 9-Hole Peg tests are physical assessments used by neurologists to measure ataxia, leg coordination, and hand dexterity in people with ARSACS. Tracking these scores over time helps your care team adjust therapies and introduce helpful mobility aids at the right time.

When you visit the neurologist for ARSACS (Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay), your care team will likely ask you to perform a series of walking, tapping, and peg-placing exercises. These are standardized clinical assessments—specifically the SARA, LEMOCOT, and 9-Hole Peg Test. They are designed to objectively measure your coordination, balance, and fine motor skills. By turning your symptoms into numerical scores, your doctor can track how your condition is changing over time, make informed adjustments to your physical or occupational therapies, and collect vital data that helps drive ARSACS research and clinical trials [1][2]. (Tip: Because these tests involve moving your arms, legs, and walking, it is helpful to wear comfortable clothing and easy-to-remove shoes to your neurology appointments.)

The Scale for the Assessment and Rating of Ataxia (SARA)

The Scale for the Assessment and Rating of Ataxia (SARA) is a tool used to evaluate the overall severity of ataxia, which is the lack of muscle control and coordination common in ARSACS [1][3].

During the SARA assessment, your neurologist will ask you to perform eight different tasks. These evaluate your gait (walking), stance (balance while standing), sitting balance, speech clarity, and how well you can coordinate your arms and legs [3].

What the score means:
Scores are added up, and a higher total score indicates a greater level of impairment [3][4]. SARA is widely recognized as a reliable way to quickly detect changes in ataxia symptoms during busy clinical visits [5][6]. Tracking this score helps your doctor understand your overall disease progression [4].

The Lower Extremity Motor Coordination Test (LEMOCOT)

Because ARSACS significantly affects the lower body, your doctor may use the Lower Extremity Motor Coordination Test (LEMOCOT) [7]. This test specifically measures how well you can control and coordinate the movements of your legs [7].

In this test, you are typically asked to tap your big toe between two targets as quickly and accurately as possible within a 20-second timeframe [7].

What the score means:
Your score is based on the number of accurate target taps you complete [8]. A lower score indicates poorer lower-limb coordination [7]. Tracking this over time is crucial for deciding when physical therapy exercises should be adjusted or when it might be time to consider mobility aids (like a walker or wheelchair). While transitioning to a mobility aid can be an emotionally difficult milestone, tracking your scores helps ensure these tools are introduced at the exact right time to keep you safe and maximize your independence [9][10].

The 9-Hole Peg Test (9HPT)

The 9-Hole Peg Test (9HPT) measures manual dexterity and upper-extremity (arm and hand) motor function [11][12]. You will be asked to take nine small pegs and place them into nine holes on a board as fast as you can, and then remove them [11]. To account for varying levels of ability, you might be asked to complete two trials per hand [13].

What the score means:
The score is the amount of time it takes to complete the task [11]. Longer completion times indicate a decline in hand coordination and fine motor skills [12]. If your time increases significantly over several visits, it signals to your care team that you might benefit from occupational therapy or adaptive tools for daily tasks like buttoning shirts or using utensils [11][14].

Why These Scores Matter for Your Care and Research

While ARSACS involves a “triad” of symptoms—ataxia, spasticity (muscle stiffness), and neuropathy (nerve damage)—these three tests specifically focus on tracking your ataxia and motor coordination [2]. They provide essential, objective data that benefits you in several ways:

  • Adjusting Therapies: If your scores show a decline in specific areas, your care team can proactively adjust your physical and occupational therapies, or introduce new strategies like wheelchair-skills training to improve your daily independence [9][15].
  • Clinical Trials and Registries: These tests provide a standardized way to measure ARSACS progression [1]. When your scores are added to disease registries (with your permission), they help researchers understand the natural history of the disease [16]. If a new treatment is developed, these tests will be used to prove whether the therapy is working [17][18].
  • Comprehensive Assessment: Sometimes, doctors also use the DSI-ARSACS (Disease Severity Index for ARSACS), a scale specifically developed for adults with ARSACS. Because it is closely correlated with your SARA, LEMOCOT, and 9-Hole Peg scores, your doctor can often evaluate your overall disease severity without needing to put you through a completely different set of exhausting physical tasks [2].

The Emotional Toll of Testing

Repeating these assessments at every visit and watching your times get slower or your scores change can be emotionally exhausting and discouraging. It is completely normal to feel anxious or upset before these tests. Remember that your doctor is primarily comparing your scores to your own past performance—your personal baseline—not to a “perfect” standard [4]. The goal is not to pass or fail, but to understand exactly where you are today so your care team can give you the best possible support.

Common questions in this guide

What does the SARA test measure for ARSACS?
The Scale for the Assessment and Rating of Ataxia (SARA) evaluates the overall severity of your ataxia. It measures your muscle control, including your gait, standing and sitting balance, arm and leg coordination, and speech clarity. A higher score means a greater level of impairment.
How is the LEMOCOT test performed?
The Lower Extremity Motor Coordination Test (LEMOCOT) measures your leg coordination. During the test, you will be asked to tap your big toe between two targets as quickly and accurately as possible for 20 seconds. A lower number of taps indicates poorer lower-limb control.
What does a longer time on the 9-Hole Peg Test mean?
The 9-Hole Peg Test measures your manual dexterity and fine motor skills by timing how quickly you can place and remove nine small pegs on a board. If your completion time increases over several visits, it indicates a decline in hand coordination and may signal the need for occupational therapy.
Why do neurologists track these physical test scores?
Tracking your scores over time gives doctors objective data about your disease progression. This helps them know exactly when to adjust your physical therapies, introduce mobility aids, or recommend occupational therapy to help you maintain your daily independence.
Is it normal to feel anxious about taking physical tests for ARSACS?
It is completely normal to feel emotionally exhausted or anxious about these assessments. Remember that your doctor is comparing your scores to your own past performance to give you the best support, not judging you against a perfect standard. Let your doctor know if you are experiencing testing anxiety.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How much have my scores changed since my last visit, and what does that mean for my current treatment plan?
  2. 2.Which specific score or area concerns you the most right now?
  3. 3.Are there daily exercises I can do at home to help maintain my 9-Hole Peg Test time or LEMOCOT score?
  4. 4.Based on my SARA score, should we adjust my physical or occupational therapy goals?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Documenting the psychometric properties of the scale for the assessment and rating of ataxia to advance trial readiness of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

    Bourcier D, Bélanger M, Côté I, et al.

    Journal of the neurological sciences 2020; (417()):117050 doi:10.1016/j.jns.2020.117050.

    PMID: 32736199
  2. 2

    Development and validation of a disease severity index for ataxia of Charlevoix-Saguenay.

    Gagnon C, Brais B, Lessard I, et al.

    Neurology 2019; (93(16)):e1543-e1549 doi:10.1212/WNL.0000000000008313.

    PMID: 31534027
  3. 3

    Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias.

    Hamdan A, Hooker AC, Chen X, et al.

    CPT: pharmacometrics & systems pharmacology 2024; (13(8)):1327-1340 doi:10.1002/psp4.13162.

    PMID: 38769902
  4. 4

    Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.

    Reetz K, Dogan I, Hilgers RD, et al.

    The Lancet. Neurology 2016; (15(13)):1346-1354 doi:10.1016/S1474-4422(16)30287-3.

    PMID: 27839651
  5. 5

    Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia.

    Salcı Y, Fil A, Keklicek H, et al.

    Multiple sclerosis and related disorders 2017; (18()):135-140 doi:10.1016/j.msard.2017.09.032.

    PMID: 29141795
  6. 6

    Ataxia Rating Scales: Content Analysis by Linking to the International Classification of Functioning, Disability and Health.

    Etoom M, Jahan AM, Alghwiri A, et al.

    Healthcare (Basel, Switzerland) 2022; (10(12)) doi:10.3390/healthcare10122459.

    PMID: 36553983
  7. 7

    Validity and reliability of the LEMOCOT in the adult ARSACS population: A measure of lower limb coordination.

    Lessard I, Lavoie C, Côté I, et al.

    Journal of the neurological sciences 2017; (377()):193-196 doi:10.1016/j.jns.2017.03.046.

    PMID: 28477695
  8. 8

    Insights into motor performance deficits after stroke: an automated and refined analysis of the lower-extremity motor coordination test (LEMOCOT).

    Handelzalts S, Koren Y, Goldhamer N, et al.

    Journal of neuroengineering and rehabilitation 2021; (18(1)):155 doi:10.1186/s12984-021-00950-z.

    PMID: 34702299
  9. 9

    Wheelchair mobility, motor performance and participation of adult wheelchair users with ARSACS: a cross-sectional study.

    Bourassa J, Routhier F, Gagnon C, et al.

    Disability and rehabilitation. Assistive technology 2023; (18(4)):378-386 doi:10.1080/17483107.2020.1858195.

    PMID: 33307884
  10. 10

    Functional mobility in walking adult population with ataxia of Charlevoix-Saguenay.

    Lessard I, St-Gelais R, Hébert LJ, et al.

    Orphanet journal of rare diseases 2021; (16(1)):432 doi:10.1186/s13023-021-02054-2.

    PMID: 34649570
  11. 11

    Smartphone-based remote assessment of upper extremity function for multiple sclerosis using the Draw a Shape Test.

    Creagh AP, Simillion C, Scotland A, et al.

    Physiological measurement 2020; (41(5)):054002 doi:10.1088/1361-6579/ab8771.

    PMID: 32259798
  12. 12

    Bibliometric Analysis of Research on the Use of the Nine Hole Peg Test.

    Moreno-Morente G, Hurtado-Pomares M, Terol Cantero MC

    International journal of environmental research and public health 2022; (19(16)) doi:10.3390/ijerph191610080.

    PMID: 36011713
  13. 13

    Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.

    Kierkegaard M, Petitclerc E, Hébert LJ, Gagnon C

    Neuromuscular disorders : NMD 2017; (27(2)):153-158 doi:10.1016/j.nmd.2016.11.018.

    PMID: 28062219
  14. 14

    Natural History of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay: a 4-Year Longitudinal Study.

    Lessard I, Côté I, St-Gelais R, et al.

    Cerebellum (London, England) 2024; (23(2)):489-501 doi:10.1007/s12311-023-01558-w.

    PMID: 37101017
  15. 15

    Efficacy of Manual Wheelchair Skills Training for Improving Skills and Confidence in People With Hereditary Degenerative Disorders: Protocol for a Sequential Multimethods Study.

    Niyomwungere E, Routhier F, Gagnon C, et al.

    JMIR research protocols 2025; (14()):e66974 doi:10.2196/66974.

    PMID: 40742628
  16. 16

    From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.

    Gagnon C, Brais B, Lessard I, et al.

    Orphanet journal of rare diseases 2018; (13(1)):165 doi:10.1186/s13023-018-0898-z.

    PMID: 30231904
  17. 17

    Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.

    Cutellè C, Rastelli E, Gibellini M, et al.

    Neuromuscular disorders : NMD 2018; (28(11)):947-951 doi:10.1016/j.nmd.2018.08.011.

    PMID: 30270126
  18. 18

    Digital health metrics reveal upper limb impairment profiles in ARSACS.

    Kanzler CM, Lessard I, Gassert R, et al.

    Journal of the neurological sciences 2023; (448()):120621 doi:10.1016/j.jns.2023.120621.

    PMID: 37004405

This page is for informational purposes only and does not replace professional medical advice. Always discuss your test scores, symptom progression, and care plan directly with your neurologist.

Get notified when new evidence is published on Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.